Literature DB >> 10051135

Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function.

N J Edmunds1, H Lal, B Woodward.   

Abstract

1. The cardiac depressant actions of TNF were investigated in the isolated perfused rat heart under constant flow (10 ml min(-1)) and constant pressure (70 mmHg) conditions, using a recirculating (50 ml) mode of perfusion. 2. Under constant flow conditions TNF (20 ng ml(-1)) caused an early (< 25 min) decrease in left ventricular developed pressure (LVDP), which was maintained for 90 min (LVDP after 90 min: control vs TNF; 110 +/- 4 vs 82 +/- 10 mmHg, P < 0.01). 3. The depression in cardiac function seen with TNF under constant flow conditions, was blocked by the ceramidase inhibitor N-oleoylethanolamine (NOE), 1 microM, (LVDP after 90 min: TNF vs TNF with NOE; 82 +/- 10 vs 11 +/- 5 mmHg, P < 0.05). 4. In hearts perfused at constant pressure, TNF caused a decrease in coronary flow rate (change in flow 20 min after TNF: control vs TNF; -3.0 +/- 0.9 vs -8.7 +/- 1.2 ml min(-1), P < 0.01). This was paralleled by a negative inotropic effect (change in LVDP 20 min after TNF: control vs TNF; -17 +/- 7 vs -46 +/- 6 mmHg, P < 0.01). The decline in function was more rapid and more severe than that seen under conditions of constant flow. 5. These data indicate that cardiac function can be disrupted by TNF on two levels, firstly via a direct, ceramidase dependant negative inotropic effect, and secondly via an indirect coronary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051135      PMCID: PMC1565798          DOI: 10.1038/sj.bjp.0702294

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

3.  Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis.

Authors:  S C Smith; P M Allen
Journal:  Circ Res       Date:  1992-04       Impact factor: 17.367

4.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

5.  Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C-dependent Na(+)-H+ exchanger.

Authors:  B K Krämer; T W Smith; R A Kelly
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

6.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

7.  Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study.

Authors:  E Arbustini; M Grasso; M Diegoli; M Bramerio; A S Foglieni; M Albertario; L Martinelli; A Gavazzi; C Goggi; C Campana
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

Review 8.  Sphingomyelin and derivatives as cellular signals.

Authors:  R N Kolesnick
Journal:  Prog Lipid Res       Date:  1991       Impact factor: 16.195

9.  Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system.

Authors:  K A Dressler; S Mathias; R N Kolesnick
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

10.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

Authors:  J C Mathison; E Wolfson; R J Ulevitch
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more
  9 in total

1.  Negative inotropic effects of tumour necrosis factor-alpha and interleukin-1beta are ameliorated by alfentanil in rat ventricular myocytes.

Authors:  D J Duncan; P M Hopkins; S M Harrison
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

2.  The role of 17-beta estradiol in ischemic preconditioning protection of the heart.

Authors:  Fawzi A Babiker; Lamia J Hoteit; Shaji Joseph; Abu Salim Mustafa; Jasbir S Juggi
Journal:  Exp Clin Cardiol       Date:  2012-09

3.  The effect of diazepam on myocardial function and coronary vascular tone after endotoxemia in the isolated rat heart model.

Authors:  William M L Neethling; Andrew J Hodge
Journal:  Inflamm Res       Date:  2010-08-06       Impact factor: 4.575

4.  Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.

Authors:  Reza Tabrizchi; Carol Ann Ford
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-18       Impact factor: 3.000

Review 5.  Toward Human Models of Cardiorenal Syndrome in vitro.

Authors:  Beatrice Gabbin; Viviana Meraviglia; Christine L Mummery; Ton J Rabelink; Berend J van Meer; Cathelijne W van den Berg; Milena Bellin
Journal:  Front Cardiovasc Med       Date:  2022-05-26

Review 6.  Tumor Necrosis Factor-α in Heart Failure: an Updated Review.

Authors:  Sarah M Schumacher; Sathyamangla V Naga Prasad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

Review 7.  Proinflammatory Cytokines Mediate GPCR Dysfunction.

Authors:  Maradumane L Mohan; Neelakantan T Vasudevan; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2017-08       Impact factor: 3.105

8.  Platelets and cardiac arrhythmia.

Authors:  Jonas S S G de Jong; Lukas R C Dekker
Journal:  Front Physiol       Date:  2010-12-30       Impact factor: 4.566

Review 9.  Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.

Authors:  L Di Lullo; A Bellasi; V Barbera; D Russo; L Russo; B Di Iorio; M Cozzolino; C Ronco
Journal:  Indian Heart J       Date:  2017-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.